Evaluation of DHAD in Gynecologic Cancers

Closed

Phase

Published

Abbreviated Title

Activated

10/20/1980

Closed

10/03/1984

Publication Information Expand/Collapse

1986

Mitoxantrone and advanced squamous cell carcinoma of the cervix.A Southwest Oncology Group study.

RD Hilgers;DD Von Hoff;RL Stephens;JG Boutselis Cancer Treat Rep 70(4):527-528

1985

Mitoxantrone in adenocarcinoma of the endometrium: A Southwest Oncology Group study.

RD Hilgers;DD Von Hoff;RL Stephens;JG Boutselis;SE Rivkin Cancer Treat Rep 69(11):1329-1330

1984

Mitoxantrone in epithelial carcinoma of the ovary. A Southwest Oncology Group study.

RD Hilgers;DD Von Hoff;SE Rivkin;DS Alberts Am J Clin Oncol 7(5):499-501

1983

Southwest Oncology Group Phase II studies with Mitoxantrone in nonhematologic malignancies.

RL Stephens;DD Von Hoff;SA Taylor;WA Knight III;RB Livingston;FE Bull;J Cowan;RD Hilgers;CK Osborne;GA Gates;G Clark In: New Anticancer Drugs: Mitoxantrone and Bisantrene . M Rozencweig, et al, eds. New York: Raven Press, 125-30

Cardiotoxicity in patients treated with Mitoxantrone on Southwest Oncology Group Phase II protocols.

GM Clark;LK Tokaz;DD Von Hoff;LL Thoi;CA Coltman Jr Cancer Treat Symp 3:25-30

1981

Southwest Oncology Group (SWOG) Phase II with mitoxantrone in non-hematologic malignancies.

RL Stephens;G Clark 3rd NCI-EORTC Symposium on New Drugs in Cancer Therapy (October 15-17, 1981), #36